RSLS
Income statement / Annual
Last year (2023), ReShape Lifesciences Inc.'s total revenue was $8.68 M,
a decrease of 22.79% from the previous year.
In 2023, ReShape Lifesciences Inc.'s net income was -$11.39 M.
See ReShape Lifesciences Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$8.68 M
|
$11.24 M
|
$13.60 M
|
$11.30 M
|
$15.09 M
|
$606,710.00
|
$1.29 M
|
$786,660.00
|
$292,000.00
|
$0.00
|
| Cost of Revenue |
$3.13 M |
$4.44 M |
$5.25 M |
$5.04 M |
$5.78 M |
$164,299.00 |
$936,386.00 |
$431,476.00 |
$125,000.00 |
$0.00 |
| Gross Profit |
$5.55 M |
$6.80 M |
$8.35 M |
$6.26 M |
$9.31 M |
$442,411.00 |
$350,768.00 |
$355,184.00 |
$167,000.00 |
$0.00 |
| Gross Profit Ratio |
0.64 |
0.61 |
0.61 |
0.55 |
0.62 |
0.73 |
0.27 |
0.45 |
0.57 |
0 |
| Research and Development
Expenses |
$2.32 M
|
$2.54 M
|
$2.52 M
|
$3.50 M
|
$3.12 M
|
$5.72 M
|
$5.78 M
|
$5.17 M
|
$8.14 M
|
$11.03 M
|
| General & Administrative
Expenses |
$10.32 M
|
$17.25 M
|
$24.41 M
|
$10.53 M
|
$17.22 M
|
$19.26 M
|
$25.98 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$7.55 M
|
$14.09 M
|
$9.17 M
|
$4.69 M
|
$4.85 M
|
$5.24 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$17.87 M
|
$31.34 M
|
$33.58 M
|
$15.22 M
|
$22.07 M
|
$19.26 M
|
$25.98 M
|
$17.98 M
|
$19.89 M
|
$14.56 M
|
| Other Expenses |
$122,000.00 |
$11,000.00 |
$23.50 M |
$306,000.00 |
-$1.34 M |
-$10,643.00 |
-$652.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$20.19 M |
$33.88 M |
$36.10 M |
$18.72 M |
$25.19 M |
$24.98 M |
$31.76 M |
$23.15 M |
$28.03 M |
$25.59 M |
| Cost And Expenses |
$23.32 M |
$38.32 M |
$41.35 M |
$23.76 M |
$30.98 M |
$25.15 M |
$32.70 M |
$23.58 M |
$28.16 M |
$25.59 M |
| Interest Income |
$0.00 |
$113,000.00 |
$832,000.00 |
$2.05 M |
$451,000.00 |
$0.00 |
$1,066.00 |
$5,837.00 |
$1,819.00 |
$3,331.00 |
| Interest Expense |
-$26,000.00 |
$113,000.00 |
$832,000.00 |
$2.05 M |
$451,000.00 |
$12,378.00 |
$3,874.00 |
$4.10 M |
$939,182.00 |
$530,222.00 |
| Depreciation &
Amortization |
$154,000.00
|
$2.15 M
|
$1.97 M
|
$1.67 M
|
$894,000.00
|
$581,000.00
|
$330,000.00
|
$192,000.00
|
$188,606.00
|
$188,904.00
|
| EBITDA |
-$14.49 M
|
-$24.91 M
|
-$27.75 M
|
-$12.46 M
|
-$17.22 M
|
-$24.11 M
|
-$31.41 M
|
-$22.79 M
|
-$30.24 M
|
-$25.06 M
|
| EBITDA Ratio |
-1.67 |
-2.22 |
-2.04 |
-1.1 |
-1.14 |
-39.74 |
-24.4 |
-28.97 |
-103.54 |
0 |
| Operating Income Ratio
|
-1.69
|
-2.41
|
-2.04
|
-1.1
|
-1.05
|
-63.53
|
-24.4
|
-28.98
|
-95.43
|
0
|
| Total Other
Income/Expenses Net |
$3.30 M
|
-$19.52 M
|
-$34.29 M
|
-$9.35 M
|
-$59.21 M
|
-$14.16 M
|
-$4.72 M
|
$3.53 M
|
$2.37 M
|
-$536,000.00
|
| Income Before Tax |
-$11.34 M |
-$46.59 M |
-$62.04 M |
-$21.81 M |
-$75.10 M |
-$38.71 M |
-$36.13 M |
-$23.36 M |
-$25.50 M |
-$26.13 M |
| Income Before Tax Ratio
|
-1.31
|
-4.15
|
-4.56
|
-1.93
|
-4.98
|
-63.81
|
-28.07
|
-29.7
|
-87.33
|
0
|
| Income Tax Expense |
$52,000.00 |
-$380,000.00 |
-$106,000.00 |
-$181,000.00 |
-$893,000.00 |
-$3.45 M |
-$2.31 M |
$3.96 M |
-$2.56 M |
$347,096.00 |
| Net Income |
-$11.39 M |
-$46.21 M |
-$61.93 M |
-$21.63 M |
-$74.21 M |
-$81.15 M |
-$33.82 M |
-$23.36 M |
-$25.50 M |
-$26.13 M |
| Net Income Ratio |
-1.31 |
-4.11 |
-4.55 |
-1.91 |
-4.92 |
-133.76 |
-26.27 |
-29.7 |
-87.33 |
0 |
| EPS |
-1.91 |
-108.9 |
-283.42 |
-830.93 |
-2364.94 |
-6394.42 |
-3034.63 |
-8299.89 |
-2289.99 |
0 |
| EPS Diluted |
-1.91 |
-108.9 |
-283.42 |
-830.93 |
-2364.94 |
-6394.42 |
-3034.63 |
-8299.89 |
-2289.99 |
0 |
| Weighted Average Shares
Out |
$5.96 M
|
$424,390.00
|
$218,522.00
|
$26,031.00
|
$31,378.00
|
$12,691.00
|
$11,144.00
|
$2,814.60
|
$11,135.00
|
$0.00
|
| Weighted Average Shares
Out Diluted |
$5.96 M
|
$424,390.00
|
$218,522.00
|
$26,031.00
|
$31,378.00
|
$12,691.00
|
$11,144.00
|
$2,814.60
|
$11,135.00
|
$0.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
